Domestic and International Exchange Dynamics-YINFENG LIFE EXTENSION PROGRAM

EN丨CN

International Life Extension Research Alliance

Domestic and International Exchange Dynamics

Video Center

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

2026/07/22

The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

2026/04/24

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

2026/03/04

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

2026/02/02

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

2026/01/19

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

2026/01/04

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.

2021-11-04

→

Hard-won! my country’s first “frozen baby” undergoes health review

Recently, Beijing Obstetrics and Gynecology Hospital welcomed a special baby. This is the first child in China to become pregnant naturally after a successful transplant of cryopreserved ovarian tissue. The 45-day re-examination results showed that all indicators of the baby were normal and everything was healthy!

2021-10-27

→

A world first! Pig kidney transplanted into human body, functions normally, no rejection yet

Recently, NYU Langone Medical Center conducted a special experiment - transplanting kidneys from pigs into humans for the first time, and there has been no rejection reaction so far. The kidney for this experiment came from a gene-edited pig.

2021-10-27

→

Another big guy joins! The ultimate pursuit of many entrepreneurs is this

On October 20, 2021, the Cryogenic Medicine Research Center of Shandong Yinfeng Life Sciences Research Institute (the research unit of our foundation) welcomed the Yinfeng second-generation upgraded high-precision, long-span, and large-scale programmed cooling instrument. The overall appearance of this equipment , the operation interface, the spatial layout of the temperature monitoring sensor, and the traveling mode of the liquid nitrogen steam vortex have all been optimized and upgraded.

2021-09-02

→

Pay tribute to the heroes behind the scenes - using experimental data to support the exploration of life sciences

Research in basic science is supported by experimental data one by one, and the same is true for exploration in life sciences. The generation of every experimental data is inseparable from the contribution and dedication of experimental animals, and they are all precious.

2021-02-25

→

Yinfeng Institute of Biological Sciences’ research results on “Stem Cells Promote New Bone Growth” were published in foreign journals

Large-segment bone defects are common clinical diseases, and stem cells and bone tissue engineering are considered to be a promising method for bone regeneration. Recently, a team from Shandong Yinfeng Life Sciences Research Institute and Shandong University collaborated to study a nanocellulose membrane platform for multi-lineage differentiation of stem cells to biomimetically construct bioactive three-dimensional bone-like tissue, which can significantly promote the rapid growth of new bone and capillary growth. Rapid formation of blood vessels and nerve fibers.

2021-01-21

→

Shandong Regional Traditional Chinese Medicine Stem Cell Healthcare Collaborative Innovation Cooperation Community

Shandong Academy of Traditional Chinese Medicine and Shandong Yinfeng Institute of Life Sciences are working together to create a collaborative innovation and cooperation community between traditional Chinese medicine and stem cell healthcare in the Shandong region. Modern active ingredient extraction technology of traditional Chinese medicine is used to conduct research on stem cell technology and products, creating a healthcare industry with Chinese characteristics.